These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


79 related items for PubMed ID: 21715432

  • 1. Comparison of the effects of the n-3 polyunsaturated fatty acid eicosapentaenoic and fenofibrate on the inhibitory effect of arthritis on IGF1.
    Castillero E, López-Menduiña M, Martín AI, Villanúa MÁ, López-Calderón A.
    J Endocrinol; 2011 Sep; 210(3):361-8. PubMed ID: 21715432
    [Abstract] [Full Text] [Related]

  • 2. Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats.
    López-Menduiña M, Martín AI, Castillero E, Villanúa MA, López-Calderón A.
    Growth Horm IGF Res; 2012 Feb; 22(1):22-9. PubMed ID: 22244673
    [Abstract] [Full Text] [Related]

  • 3. Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats.
    Granado M, Priego T, Martín AI, Vara E, López-Calderón A, Angeles Villanúa M.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):204-10. PubMed ID: 16545800
    [Abstract] [Full Text] [Related]

  • 4. Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy.
    Castillero E, Nieto-Bona MP, Fernández-Galaz C, Martín AI, López-Menduiña M, Granado M, Villanúa MA, López-Calderón A.
    Am J Physiol Endocrinol Metab; 2011 May 24; 300(5):E790-9. PubMed ID: 21304067
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporin a treatment is able to revert the decrease in circulating GH and IGF-I and the increase in IGFBPs induced by adjuvant arthritis.
    Soto L, Martín AI, Vara E, López-Calderón A.
    Horm Metab Res; 2001 Oct 24; 33(10):590-5. PubMed ID: 11607878
    [Abstract] [Full Text] [Related]

  • 6. Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3.
    López-Menduiña M, Martín AI, Castillero E, Villanúa MA, López-Calderón A.
    Am J Physiol Regul Integr Comp Physiol; 2010 Aug 24; 299(2):R541-51. PubMed ID: 20519361
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors.
    Castillero E, Martín AI, López-Menduiña M, Villanúa MA, López-Calderón A.
    Am J Physiol Regul Integr Comp Physiol; 2009 Nov 24; 297(5):R1322-31. PubMed ID: 19741054
    [Abstract] [Full Text] [Related]

  • 9. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle.
    Granado M, Priego T, Martín AI, Villanúa MA, López-Calderón A.
    Am J Physiol Endocrinol Metab; 2005 Dec 24; 289(6):E1007-14. PubMed ID: 16030067
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Melanocortin-4 receptor agonist (RO27-3225) ameliorates soleus but not gastrocnemius atrophy in arthritic rats.
    Gomez-Sanmiguel AB, Nieto-Bona MP, Fernandez-Galaz C, Priego T, Martin AI, Lopez-Calderon A.
    J Physiol Pharmacol; 2017 Apr 24; 68(2):191-199. PubMed ID: 28614768
    [Abstract] [Full Text] [Related]

  • 12. NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver.
    Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A.
    Am J Physiol Endocrinol Metab; 2004 Jan 24; 286(1):E50-6. PubMed ID: 13129855
    [Abstract] [Full Text] [Related]

  • 13. Comparative study between the effect of the peroxisome proliferator activated receptor-alpha ligands fenofibrate and n-3 polyunsaturated fatty acids on activation of 5'-AMP-activated protein kinase-alpha1 in high-fat fed rats.
    Motawi TM, Hashem RM, Rashed LA, El-Razek SM.
    J Pharm Pharmacol; 2009 Oct 24; 61(10):1339-46. PubMed ID: 19814866
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dexamethasone administration attenuates the inhibitory effect of lipopolysaccharide on IGF-I and IGF-binding protein-3 in adult rats.
    Priego T, Granado M, Martín AI, López-Calderón A, Villanúa MA.
    J Endocrinol; 2005 Jun 24; 185(3):467-76. PubMed ID: 15930173
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Down-regulation in muscle and liver lipogenic genes: EPA ethyl ester treatment in lean and overweight (high-fat-fed) rats.
    Pérez-Echarri N, Pérez-Matute P, Marcos-Gómez B, Marti A, Martínez JA, Moreno-Aliaga MJ.
    J Nutr Biochem; 2009 Sep 24; 20(9):705-14. PubMed ID: 18829285
    [Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase-2 [corrected] activation by endotoxin mediates the decrease in IGF1, but not in IGFBP3, [corrected] gene expression in the liver.
    Martín AI, López-Menduiña M, Castillero E, Granado M, Villanúa MA, López-Calderón A.
    J Endocrinol; 2008 Aug 24; 198(2):385-94. PubMed ID: 18492809
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.